Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Revenio Group

19.04 EUR

-0.10 %

14,279 following
Corporate customer

REG1V

NASDAQ Helsinki

Medical Equipment & Services

Health Care

-0.10 %
+2.37 %
-15.00 %
-15.00 %
-17.93 %
-24.50 %
-50.72 %
-63.03 %
+902.11 %

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more
Market cap
508.01M EUR
Turnover
420.12K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Buy
Target price
Updated
12.02.2026
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Latest research

Latest analysis report

Released: 12.02.2026

Latest extensive report

Released: 21.01.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
15.4.
2026

General meeting '26

28.4.
2026

Interim report Q1'26

6.8.
2026

Interim report Q2'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Revenio Q4'25 preview: Valuation reaches historic lows
Research by
Juha Kinnunen

Revenio Q4'25 preview: Valuation reaches historic lows

Revenio's valuation has fallen to a historically low level, as the industry faces concerns, especially after Zeiss's grim profit warning. We consider the concerns regarding Revenio to be exaggerated and estimate the company's earnings to be firmly on an upward trend this year.

Revenio Group
Revenio Q3'25: Q4 will decide this year too
Research by
Juha Kinnunen

Revenio Q3'25: Q4 will decide this year too

Revenio's Q3 earnings fell short of our overly optimistic expectations, but on the other hand, the Q4 outlook appears better than we anticipated. There have been no dramatic revisions in the outlook for the coming years, but the market is showing at least small signs of recovery.

Revenio Group
Forum discussions
However, this point is interesting: 20. Amendment of Article 4 of the Articles of Association The Board of Directors proposes that Article 4 of the Articles of Association be amended such that the maximum number of ordinary members of the Board of Directors changes from seven (7)...
3/23/2026, 2:55 PM
by Sissos
35
Apparently, CEO Toijala has enough time to focus outside of Revenio, as he is a candidate for QT’s board of directors. In my opinion, in smaller companies, resources are so limited that there would be plenty to invest in one’s own company, be it customer relationships, new market...
3/20/2026, 7:26 AM
by Opa
26
Spotted on Nordnet, nothing new or amazing, but perhaps people will wake up a bit regarding Revenio:
3/31/2026, 10:29 AM
by MTES
21
This is a pretty convincing picture. Halfway to becoming a Dividend Aristocrat. Are the years when the dividend remained the same counted, or only the years when the dividend increased? Well, they certainly grow. But what about extra dividends?
3/23/2026, 3:16 PM
by Sissos
13
Well, now it’s high time to jump ship. Getinge, Volati, and Revenio all seem to have gotten undeserved appreciation during the corona turmoil and haven’t done anything for years. However, all of them have a similar nice profile; “you’ll never get these at a P/E of ten”. I guess one...
3/31/2026, 12:44 PM
by tankerous
10
I find it noteworthy that Revenio has not yet issued a notice of the annual general meeting. Perhaps this is due to M&A matters. At least in the past couple of years, the notice of the annual general meeting had already been issued by this time.
3/20/2026, 7:44 AM
by MTES
9
Bråsen’s predictions were pretty accurate when he worked as an analyst for DI. Four other companies might also be worth looking into. Swedes could put on their buying pants and start stocking up on Revenio.
3/31/2026, 12:39 PM
by Matkalle...
8
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.